Related Experiment Video
Updated: Jun 20, 2026

Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein
Published on: July 27, 2016
A Novel Approach to Manage Hypercholesterolemia: Veterans Affairs Lipid Optimization Reimagined Quality Improvement
Luc Djousse1, Rachel E Ward2, Helen Marucci-Wellman2
1MAVERIC, Boston VA Healthcare System, Boston, MA, USA; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Insights
Lipid optimization strategies improved low-density lipoprotein cholesterol (LDL-C) control in veterans with atherosclerotic cardiovascular disease (ASCVD). Tailored interventions increased LDL-C goal achievement and medication adherence.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Quality Improvement
Background:
- Elevated low-density lipoprotein cholesterol (LDL-C) is a primary risk factor for atherosclerotic cardiovascular disease (ASCVD).
- Despite available treatments, LDL-C goals are unmet in a majority of veterans with ASCVD.
- Current lipid management strategies require optimization for improved patient outcomes.
Purpose of the Study:
- To evaluate the effectiveness of tailored lipid optimization strategies in improving LDL-C control among veterans.
- To assess the impact of these strategies on the utilization and patient adherence to lipid-lowering therapy (LLT).
- To identify site-specific barriers and implement targeted interventions for enhanced lipid management.
Main Methods:
- A quality improvement program involving 167,505 veterans with prevalent ASCVD across 50 Veterans Affairs Medical Centers.
- Collaboration between American Heart Association consultants and local providers to identify and address barriers to lipid management.
- Primary outcome measured was the proportion of veterans achieving an LDL-C <70 mg/dL at 24 months.
Main Results:
- 34.4% of veterans achieved the LDL-C goal (<70 mg/dL) at 24 months, a significant improvement (P < 0.001).
- Mean LDL-C levels decreased by 16.6 mg/dL.
- Use of LLT increased from 77.4% to 87.8%, and adherence to LLT rose from 56.3% to 65.1%.
Conclusions:
- Addressing site-specific barriers to lipid management effectively improves LDL-C control in veterans with ASCVD.
- Tailored interventions are crucial for enhancing lipid-lowering therapy utilization and adherence.
- This quality improvement initiative demonstrates a successful model for optimizing cardiovascular risk management in a veteran population.
Background:
Elevated serum low-density lipoprotein cholesterol (LDL-C) is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Despite the availability of effective drugs to lower LDL-C, only one-third of veterans with ASCVD have LDL-C treated to goal.
Objectives:
This study aimed to determine if a variety of lipid optimization strategies including a health coach tailored to unique barriers and needs can improve: 1) the percentage of veterans with LDL-C <70 mg/dL; and 2) the usage and patients' adherence to any lipid-lowering therapy (LLT).
Methods:
Veterans Affairs Lipid Optimization Reimagined Quality Improvement was embedded in the usual clinical care of 167,505 veterans with prevalent ASCVD inclusive of 88,778 veterans with baseline LDL-C ≥70 mg/dL in 50 Veterans Affairs Medical Centers between December 2022 and September 2025. At each Veterans Affairs site, American Heart Association consultants worked with local providers to: 1) identify barriers to lipid management; and 2) implement strategies tailored to the identified barriers. The primary outcome was the proportion of veterans with LDL-C <70 mg/dL between baseline and follow-up LDL-C measurement at 24 months.
Results:
A total of 88,778 veterans were included in current analyses with mean age of 70.0 (SD: 10.5) years and 6,250 (7.0%) women. Overall, 32.9% of veterans achieved LDL-C <70 mg/dL and for 24,610 veterans with 24-month LDL-C data, 34.4% achieved LDL-C goal (all P < 0.001). The mean LDL-C decreased by 16.6 mg/dL; use of LLT increased from 77.4% to 87.8%; and adherence to any LLT increased from 56.3% to 65.1% between baseline and 24 months.
Conclusions:
This program showed that addressing site-specific barriers to lipid management is associated with improved LDL-C among Veterans with ASCVD.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Heart Failure V: Medical Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis IV: Nursing Management